Performance analysis of Plus Therapeutics (PSTV)
Annual Return
Over the past 3 years, PSTV has had an average annual return of +0%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, PSTV has had an average annual return of +0%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, PSTV has had an average annual return of -77.87%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Nov 16, 2000, PSTV has had an average annual return of -38.64%, underperforming the benchmark SPY, which returned +8.85% annual.
| 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -50.00% | -88.24% | -80.23% | -45.22% | -62.26% | -80.98% | -8.22% | +27.30% | -57.62% | -14.91% | +68.98% | -40.34% |
| 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | ||||
| -7.49% | -21.21% | +201.88% | -9.86% | -23.74% | +25.01% | -72.77% | +0% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | +0% | -50.00% | +0% | +100% | -50.00% | +0% | +0% | +100% | -50.00% | -50.00% | |||
| 2018 | +41.18% | -20.83% | -15.79% | +0% | -6.25% | -46.67% | -50.00% | -25.00% | -33.33% | +0% | +0% | +0% | -88.24% |
| 2017 | +4.65% | +5.56% | -4.21% | -36.26% | -1.72% | +8.77% | -59.68% | -20.00% | +5% | +9.52% | -17.39% | -10.53% | -80.23% |
Drawdown analysis of Plus Therapeutics (PSTV)
The maximum drawdown for the PSTV was -99.99%, occurring on Feb 22, 2019. This drawdown has not yet recovered.
The current PSTV drawdown is -99.99%.
Since Nov 16, 2000 PSTV has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Nov 16, 2000 | 4592 | Feb 22, 2019 | Ongoing | Ongoing | Ongoing |